16:02 Dec 20
Caplin Point Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Caplin Point Laboratories Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
50/100
Medium Financial Strength
Valuation
27/100
Expensive Valuation
Technical
64/100
Technically Moderately Bullish
Strength
9
Weakness
4
Opportunity
1
Threats
0
17.57K
Market Cap (Cr)
35.60
PE Ratio
6.91
Price to Book Ratio
55.04
RSI
26.98 %
Net Profit Margin
Download Our App On:
